Family Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Family Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$279K	Hold	1,625	–	–	0.17%	90
2024 Q2	$250K	Hold	1,625	–	–	0.16%	93
2024 Q1	$250K	Hold	1,625	–	–	0.16%	95
2023 Q4	$257K	Hold	1,625	–	–	0.17%	93
2023 Q3	$238K	Hold	1,625	–	–	0.18%	87
2023 Q2	$249K	Buy	+1,625	New	+$253K	0.17%	91

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Family Asset Management's FBT Position: Q3 2024 in Review

Family Asset Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2024 at 1,625 shares worth $279K. The position accounts for 0.17% of the portfolio, ranked #90.

Family Asset Management first reported a position in FBT in Q2 2023 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold FBT as of Q3 2024.

Family Asset Management held 1,625 shares of First Trust NYSE Arca Biotechnology Index Fund worth $279K as of Q3 2024.
Family Asset Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2024.
First Trust NYSE Arca Biotechnology Index Fund made up 0.17% of Family Asset Management's portfolio in Q3 2024, its #90 holding.
Family Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2023 and has held it in 6 quarters since.
257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2024.

Based on Family Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.